Reset all filters
01 5DEFLAZACORT
02 2SEPIAPTERIN
Reset all filters
01 7PTC THERAP
Reset all filters
01 2POWDER;ORAL
02 1SUSPENSION;ORAL
03 4TABLET;ORAL
Reset all filters
01 118MG
02 11GM/PACKET
03 122.75MG/ML
04 1250MG/PACKET
05 130MG
06 136MG
07 16MG
Reset all filters
01 7USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EMFLAZA
Dosage Strength : 6MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EMFLAZA
Dosage Strength : 18MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EMFLAZA
Dosage Strength : 30MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EMFLAZA
Dosage Strength : 36MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION;ORAL
Brand Name : EMFLAZA
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2017-02-09
Application Number : 208685
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;ORAL
Brand Name : SEPHIENCE
Dosage Strength : 250MG/PACKET
Packaging :
Approval Date : 2025-07-28
Application Number : 219666
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;ORAL
Brand Name : SEPHIENCE
Dosage Strength : 1GM/PACKET
Packaging :
Approval Date : 2025-07-28
Application Number : 219666
Regulatory Info : RX
Registration Country : USA